| Year |
Citation |
Score |
| 2024 |
Bernabe CS, Caliman IF, de Abreu ARR, Molosh AI, Truitt WA, Shekhar A, Johnson PL. Identification of a novel perifornical-hypothalamic-area-projecting serotonergic system that inhibits innate panic and conditioned fear responses. Translational Psychiatry. 14: 60. PMID 38272876 DOI: 10.1038/s41398-024-02769-3 |
0.4 |
|
| 2022 |
Rodd ZA, Engleman EA, Truitt WA, Burke AR, Molosh AI, Bell RL, Hauser SR. CNO administration increases dopamine and glutamate in the medial prefrontal cortex of wistar rats: Further concerns for the validity of the CNO-activated DREADD procedure. Neuroscience. PMID 35351573 DOI: 10.1016/j.neuroscience.2022.03.028 |
0.495 |
|
| 2021 |
Gaskins DL, Burke AR, Sajdyk TJ, Truitt WA, Dietrich AD, Shekhar A. Role of Basolateral Amygdalar Somatostatin 2 Receptors in a Rat Model of Chronic Anxiety. Neuroscience. PMID 34487822 DOI: 10.1016/j.neuroscience.2021.08.031 |
0.529 |
|
| 2020 |
Knight CP, Hauser SR, Waeiss RA, Molosh AI, Johnson PL, Truitt WA, McBride WJ, Bell RL, Shekhar A, Rodd ZA. The rewarding and anxiolytic properties of ethanol within the central nucleus of the amygdala: Mediated by genetic background and nociceptin but not the CRF1 receptor. The Journal of Pharmacology and Experimental Therapeutics. PMID 32527792 DOI: 10.1124/Jpet.119.262097 |
0.348 |
|
| 2020 |
Bernabe CS, Caliman IF, Truitt WA, Molosh AI, Lowry CA, Hay-Schmidt A, Shekhar A, Johnson PL. Using loss- and gain-of-function approaches to target amygdala-projecting serotonergic neurons in the dorsal raphe nucleus that enhance anxiety-related and conditioned fear behaviors. Journal of Psychopharmacology (Oxford, England). 269881119900981. PMID 32153226 DOI: 10.1177/0269881119900981 |
0.49 |
|
| 2019 |
Johnson PL, Molosh AI, Federici LM, Bernabe C, Haggerty D, Fitz SD, Nalivaiko E, Truitt W, Shekhar A. Assessment of fear and anxiety associated behaviors, physiology and neural circuits in rats with reduced serotonin transporter (SERT) levels. Translational Psychiatry. 9: 33. PMID 30670681 DOI: 10.1038/S41398-019-0368-Y |
0.455 |
|
| 2015 |
Federici LM, Caliman IF, Molosh AI, Fitz SD, Truitt WA, Bonaventure P, Carpenter JS, Shekhar A, Johnson PL. Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model. Psychoneuroendocrinology. 65: 127-137. PMID 26765933 DOI: 10.1016/J.Psyneuen.2015.12.011 |
0.309 |
|
| 2013 |
Molosh AI, Sajdyk TJ, Truitt WA, Zhu W, Oxford GS, Shekhar A. NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1352-64. PMID 23358240 DOI: 10.1038/Npp.2013.33 |
0.321 |
|
| 2012 |
Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Progress in Brain Research. 198: 133-61. PMID 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4 |
0.325 |
|
| 2012 |
Lungwitz EA, Molosh A, Johnson PL, Harvey BP, Dirks RC, Dietrich A, Minick P, Shekhar A, Truitt WA. Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats. Physiology & Behavior. 107: 726-32. PMID 22652097 DOI: 10.1016/J.Physbeh.2012.05.019 |
0.503 |
|
| 2012 |
Johnson PL, Samuels BC, Fitz SD, Federici LM, Hammes N, Early MC, Truitt W, Lowry CA, Shekhar A. Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network. Physiology & Behavior. 107: 733-42. PMID 22554617 DOI: 10.1016/J.Physbeh.2012.04.016 |
0.578 |
|
| 2010 |
Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Träskman-Bendz L, Goddard AW, Brundin L, Shekhar A. A key role for orexin in panic anxiety. Nature Medicine. 16: 111-5. PMID 20037593 DOI: 10.1038/Nm.2075 |
0.432 |
|
| 2009 |
Obara I, Bell RL, Goulding SP, Reyes CM, Larson LA, Ary AW, Truitt WA, Szumlinski KK. Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats. Alcoholism, Clinical and Experimental Research. 33: 1924-34. PMID 19673743 DOI: 10.1111/J.1530-0277.2009.01030.X |
0.333 |
|
| 2008 |
Johnson PL, Truitt WA, Fitz SD, Lowry CA, Shekhar A. Neural pathways underlying lactate-induced panic. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2093-107. PMID 18059441 DOI: 10.1038/sj.npp.1301621 |
0.498 |
|
| 2007 |
Truitt WA, Sajdyk TJ, Dietrich AD, Oberlin B, McDougle CJ, Shekhar A. From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats. Psychopharmacology. 191: 107-18. PMID 17277936 DOI: 10.1007/S00213-006-0674-Y |
0.335 |
|
| 2005 |
Shekhar A, Truitt W, Rainnie D, Sajdyk T. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety. Stress (Amsterdam, Netherlands). 8: 209-19. PMID 16423710 DOI: 10.1080/10253890500504557 |
0.423 |
|
| 2003 |
Uphouse L, White S, Harrison L, Hiegel C, Majumdar D, Guptarak J, Truitt WA. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior. Pharmacology, Biochemistry, and Behavior. 76: 63-73. PMID 13679218 DOI: 10.1016/S0091-3057(03)00194-1 |
0.463 |
|
| 2003 |
Truitt W, Harrison L, Guptarak J, White S, Hiegel C, Uphouse L. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior. Brain Research. 974: 202-11. PMID 12742638 DOI: 10.1016/S0006-8993(03)02581-2 |
0.446 |
|
| Show low-probability matches. |